Systematic ReviewResearchPatient EducationWorkflow

Meta-analysis of 28 trials finds feedback-enhanced electronic monitoring boosts asthma inhaler adherence by 18% and cuts exacerbations

International journal of nursing studies (PubMed)Aug 10, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review and meta-analysis of 28 randomized controlled trials with 4,410 participants found that electronic inhaler monitoring coupled with active feedback increased medication adherence by 18.4% and significantly reduced acute asthma exacerbations.

What NurseJet pulled from the source

Suboptimal adherence to daily inhaled corticosteroids (ICS) is responsible for approximately 24% of all acute asthma exacerbations and remains a major challenge in pediatric and adolescent respiratory care. This systematic review and meta-analysis synthesized 28 randomized controlled trials encompassing 4,410 patients across six international databases through October 2025, evaluating electronic medication monitoring devices paired with active feedback modalities versus standard care. Study quality was evaluated using Cochrane RoB 2, and evidence certainty was graded using GRADE methodology. Feedback-enhanced electronic monitoring produced a statistically significant 18.43% absolute improvement in inhaler adherence relative to standard care (mean difference [MD]: 18.43%, 95% CI: 13.02% to 23.84%; 21 trials, 2,567 participants; moderate-certainty evidence). Adherence gains were particularly robust among pediatric cohorts (MD: 22.21%), compared with adult cohorts (MD: 14.23%) and mixed populations (MD: 23.18%). Crucially, improved adherence translated into concrete clinical benefits: asthma exacerbation rates fell significantly (MD: -2.65, 95% CI: -4.39 to -0.91; 10 trials, 1,569 participants; low certainty), while the proportion of patients achieving well-controlled asthma increased by 6.67% (MD: 6.67%, 95% CI: 4.47% to 8.86%; 5 trials, 1,709 participants). Health-related quality of life also improved on the Mini Asthma Quality of Life Questionnaire (MD: 0.26, 95% CI: 0.13 to 0.40; moderate certainty). Usability was high (SUS score 69.4 to 80.1) without an increase in adverse events.

Why this matters for nurses

Pediatric and outpatient nurses routinely provide asthma action plans and inhaler teaching, yet self-reported medication use often masks poor controller compliance until a severe exacerbation requires emergency department care or hospital admission. Demonstrating that Bluetooth sensor-enabled inhalers that deliver proactive app reminders and clinician feedback raise pediatric adherence by over 22% and prevent flare-ups provides strong evidence for integrating digital monitoring into outpatient care management.

Bedside takeaway

A meta-analysis of 28 RCTs and 4,410 patients showed feedback-enhanced electronic inhaler monitoring boosted medication adherence by 18.4% (22.2% in children) and cut exacerbations.

Key takeaways

Meta-analysis included 28 randomized controlled trials with 4,410 patients evaluating smart inhalers with active feedback.
Electronic monitoring with feedback increased overall inhaler adherence by 18.43% (95% CI: 13.02%–23.84%; moderate certainty).
Children showed the greatest adherence benefit, experiencing a 22.21% absolute increase compared to standard care.
Acute asthma exacerbation rates decreased significantly (mean difference -2.65, 95% CI: -4.39 to -0.91).
Patients achieved a 6.67% higher rate of asthma disease control alongside improved health-related quality of life.

Practice implications

Review electronic adherence data and dose counters during clinic visits and discharge counseling rather than relying solely on patient recall. Teach children, teens, and caregivers how active smart sensor alerts support routine controller habits. Verify correct spacer technique, discuss digital access barriers, and utilize objective adherence tracking to tailor dosage adjustments before escalating pharmacotherapy.

Limitations & cautions

Exacerbation and control outcomes had low-certainty ratings due to risk of bias and heterogeneity across trial definitions; Asthma Control Test score change did not reach statistical significance; device durability, digital health literacy, and health equity in underserved populations require consideration.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

International journal of nursing studies (PubMed)

International journal of nursing studies (PubMed). Feedback-enhanced electronic monitoring for asthma inhaler adherence: A systematic review and meta-analysis of randomized controlled trials.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42617523/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Nursing in critical care (PubMed)Nov 1, 2026Systematic Review

A PRISMA-guided systematic review of nurse-led interventions across neonatal, pediatric, and adult intensive care units found that combining simulation training, smart infusion pump integration, clinical decision support, and standardized protocols significantly reduced high-alert medication errors.

Med-Surg ICUAI summaryReview source

Systematic ReviewMedication SafetyQuality ImprovementWorkflowAI summary · original source linked below

Intensive care unit (ICU) clinicians routinely titrate high-alert medications—including vasoactive infusions, concentrated electrolytes, insulin, and continuous opioids—where administration errors can cause rapid patient harm. Because bedside nurses serve as the final safety checkpoint in the administration sequence, this PRISMA 2020 systematic review evaluated nurse-led interventions designed to eliminate high-alert medication errors across neonatal, pediatric, and adult ICUs. Comprehensive searching of PubMed, Web of Science, and Scopus identified six eligible interventional studies published between 2000 and 2026. Interventions incorporated simulation-based dosing scenarios, structured nurse education, smart pump dose error reduction system (DERS) integration, clinical decision support systems, and standardization of continuous infusion order sets. All six studies demonstrated significant improvements in medication safety metrics, including decreased total error rates, higher administration accuracy, and improved protocol compliance. Secondary outcomes revealed enhanced compliance with PRN medication documentation (rising from 62.0% ± 9.2% to 77.7% ± 10.1%), reduction of medication dispensing and transit intervals to under one minute, and annual institutional cost savings of $90,000 to $130,000. Risk of bias was graded moderate-to-low in five studies and high in one.

Key takeaways

Systematic review synthesized six nurse-led intervention studies across neonatal, pediatric, and adult ICU environments.
Effective bundles combined simulation training, smart pump integration, clinical decision support, and order standardization.
All reviewed studies demonstrated reductions in high-alert medication error rates and improved administration accuracy.
Compliance with PRN medication documentation improved significantly from 62.0% ± 9.2% to 77.7% ± 10.1%.
Medication dispensing intervals shortened to under one minute, with annual reported cost savings ranging from $90,000 to $130,000.

Why this matters on shift

Bedside critical care nurses titrate complex continuous infusions under urgent conditions where decimal errors, pump programming slips, or line mix-ups can trigger catastrophic cardiovascular or neurological collapse. This review demonstrates that technology like smart pumps succeeds only when paired with nursing workflow redesign, standardized concentrations, and hands-on simulation training, confirming nurses' essential role in driving medication safety systems.

Bedside takeaway

A systematic review of ICU safety studies found nurse-led bundles combining smart pumps, clinical decision support, and simulation cut high-alert medication errors and saved up to $130k annually.

Nursing implications

Strictly utilize smart pump drug libraries and dose error reduction systems for every vasoactive, sedative, and electrolyte infusion, never bypassing soft or hard limits without clinical justification. Standardize continuous infusion labeling at both the pump and distal lumen port. Actively participate in unit-based simulation and protocol reviews to identify workflow choke points, ensuring high-alert medication double-checks remain thorough and compliant with hospital safety policies.

Limitations & cautions

Heterogeneity in study designs, ICU patient populations, and error reporting definitions precluded quantitative meta-analysis, requiring narrative synthesis; only six studies met full inclusion criteria; five studies showed moderate-to-low risk of bias while one had high risk of bias; few studies evaluated low-resource or non-academic community hospital settings.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Nursing in critical care (PubMed). Nurse-Led Interventions to Mitigate High-Alert Medication Errors in Critical Care: A Systematic Review of Effectiveness and Implementation Strategies.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

AORN journal (PubMed)Nov 1, 2026Research Article

A randomized clinical trial of 105 pregnant patients undergoing cesarean delivery found that combining an underbody warming mattress with heated intravenous fluids significantly preserved maternal core temperature, reduced neonatal stress hormones, improved Apgar scores, and accelerated recovery compared with passive warming.

L&D / OB PedsAI summaryReview source

Research ArticleResearchWorkflowQuality ImprovementAI summary · original source linked below

Inadvertent perioperative hypothermia occurs frequently during cesarean delivery under neuraxial anesthesia, triggering maternal shivering, coagulopathy, increased blood loss, and neonatal cold stress. In a randomized controlled clinical trial conducted at a university hospital, 105 pregnant patients scheduled for cesarean delivery were randomized 1:1:1 into three intraoperative thermal management cohorts: underbody warmer only, underbody warmer combined with heated intravenous fluids (warmed to body temperature), or passive warming using standard hospital cotton blankets. Primary study endpoints were maternal intraoperative and postoperative core body temperatures and neonatal body temperature immediately following delivery. Secondary maternal outcomes evaluated intraoperative blood loss, postoperative analgesic consumption, and time to first flatus and spontaneous urination. Secondary neonatal outcomes measured umbilical cord blood cortisol and glucose concentrations and 1- and 5-minute Apgar scores. Active warming groups demonstrated significantly higher maternal intraoperative core temperatures and higher neonatal temperatures at birth compared with the passive blanket control group. Neonates in the active warming cohorts had significantly higher Apgar scores and reduced umbilical cord blood cortisol levels, indicating attenuated birth stress. Mothers receiving active warming experienced lower analgesic requirements and significantly faster gastrointestinal and urinary recovery.

Key takeaways

Randomized trial enrolled 105 women undergoing cesarean delivery allocated to underbody warmer, underbody warmer + heated IV fluids, or passive blankets.
Active warming significantly preserved maternal intraoperative core temperature and prevented hypothermia under spinal anesthesia.
Neonatal body temperatures at birth and Apgar scores were significantly higher in the active warming cohorts.
Cord blood cortisol levels were significantly lower in neonates whose mothers received active thermal management, indicating reduced cold-stress response.
Active intraoperative warming reduced maternal postoperative analgesic consumption and accelerated time to first flatus and spontaneous urination.

Why this matters on shift

Obstetric and perioperative nurses are directly responsible for thermal comfort, surgical safety, and newborn transition during cesarean births. Spinal anesthesia impairs maternal thermoregulation, and cold intravenous crystalloids rapidly lower maternal core temperature, which directly cools the fetal-placental circulation. Demonstrating that combined underbody warming mattresses and fluid warmers protect both maternal recovery and neonatal transition empowers nurses to champion active thermal protocols in the operating room.

Bedside takeaway

An RCT of 105 cesarean delivery patients found combining an underbody warmer with heated IV fluids maintained maternal core temperature, raised neonatal Apgar scores, and sped recovery.

Nursing implications

Implement active warming protocols—combining an underbody convective or conductive warmer with in-line fluid warming—for all scheduled cesarean deliveries prior to induction of neuraxial anesthesia. Continuously monitor maternal core temperature intraoperatively and postoperatively. Keep warmed infant blankets ready for immediate delivery, initiate early skin-to-skin contact, and observe for shivering, hemodynamic stability, and prompt return of bowel motility in the post-anesthesia care unit.

Limitations & cautions

Single-center study conducted at one university medical center with a sample size of 105 participants; blinding of operating room staff was unfeasible due to warming equipment; specific surgical blood loss volumes and long-term neonatal developmental outcomes were not detailed in the abstract.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

AORN journal (PubMed). The Effect of Using Heated IV Fluids With Underbody Warmers on Maternal and Neonatal Well-Being in Cesarean Delivery Operations: A Randomized Clinical Trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed)Oct 30, 2026Research Article

A three-arm randomized controlled trial of 227 cancer survivors with persistent chemotherapy-induced peripheral neuropathy found that a 4-week auricular point acupressure protocol significantly reduced neuropathy symptom severity at Week 1 and sustained significant reductions in neuropathy interference across all four weeks when delivered in person.

Oncology Med-SurgAI summaryReview source

Research ArticleResearchPatient EducationQuality ImprovementAI summary · original source linked below

Chemotherapy-induced peripheral neuropathy (CIPN) persists for months to years following neurotoxic antineoplastic therapy with minimal established non-pharmacological interventions. In a pragmatic three-arm randomized controlled clinical trial (ClinicalTrials.gov NCT04920097), 227 adult cancer survivors with established CIPN were randomized to receive 4 weeks of auricular point acupressure (APA) with in-person mobile app support (mAPA, n = 80), video-guided self-placement with app support (vAPA, n = 75), or standard usual oncology care (n = 72). Both APA cohorts utilized the same standardized protocol applying vaccaria seeds to designated ear acupoints with one coaching session; usual care participants received standard supportive management without study-delivered acupressure. The primary study endpoint was achieving at least a 20% reduction from baseline in an Individualized Composite Outcome (ICO) targeting each patient's highest-rated neuropathy symptom by anatomical location. Secondary endpoints evaluated neuropathy interference, functional status, and quality of life. At Week 1, both acupressure arms achieved significantly greater symptom reduction than usual care (mAPA odds ratio [OR]: 2.60, 95% CI: 1.27–5.33; vAPA OR: 3.22, 95% CI: 1.48–7.01; both p < 0.01). For the mAPA group, the symptom advantage persisted through Week 2 (OR: 2.49, p = 0.02). Notably, for neuropathy interference in daily activities, in-person mAPA significantly outperformed usual care every single week (OR range: 3.29–4.28, all p < 0.01), alongside significant exploratory improvements in anxiety, depression, and pain interference.

Key takeaways

Randomized trial enrolled 227 cancer survivors with CIPN allocated to in-person mAPA (n = 80), virtual vAPA (n = 75), or usual care (n = 72).
At Week 1, both acupressure arms significantly exceeded usual care in achieving >=20% reduction in their primary neuropathy symptom (p < 0.01).
In-person seed placement (mAPA) maintained significant symptom improvement through Week 2 (OR: 2.49, p = 0.02).
Neuropathy interference in daily living was significantly lower in the mAPA group across all four weeks of therapy (OR: 3.29–4.28, all p < 0.01).
Exploratory analyses showed concurrent reductions in anxiety, depression, and pain interference with in-person acupressure.

Why this matters on shift

Oncology and outpatient infusion nurses frequently care for cancer survivors struggling with chronic numbness, tingling, neuropathic pain, and loss of manual dexterity after taxane, platin, or vinca alkaloid regimens. Validating that a 4-week nurse-teachable auricular acupressure protocol yields rapid relief and consistently lowers neuropathy interference gives clinicians an evidence-supported, non-opioid supportive care modality to help patients regain functional independence.

Bedside takeaway

An RCT of 227 cancer survivors found 4 weeks of in-person auricular point acupressure significantly cut neuropathy symptom severity and reduced daily life interference.

Nursing implications

Routinely screen oncology patients receiving neurotoxic chemotherapy for early neuropathic sensory symptoms using validated neuropathy grading scales. For survivors experiencing persistent CIPN symptoms that interfere with buttoning, typing, or walking, discuss auricular acupressure as an adjunct to supportive care, emphasizing that initial in-person seed placement and point localization provide the greatest symptom relief. Ensure skin over the auricle is intact before seed application, instruct patients to press points 3 minutes three times daily, and discontinue seeds if local redness or irritation occurs.

Limitations & cautions

Pragmatic trial lacked sham-acupressure blinding or attention control; differential study attrition occurred with higher dropout in the virtual arm (52% completion in vAPA vs. 96% in usual care); symptom severity advantage attenuated after Week 2; long-term durability beyond the 4-week active intervention was not established.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed). Auricular point acupressure for chemotherapy-induced peripheral neuropathy: a randomized controlled trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Systematic review finds nurse-led multicomponent safety bundles reduce high-alert medication errors and streamline ICU dispensing

Randomized trial of 105 cesarean deliveries finds underbody warmers with heated IV fluids prevent maternal hypothermia and boost neonatal Apgar scores

Randomized trial of 227 cancer survivors finds auricular point acupressure significantly reduces chemotherapy-induced peripheral neuropathy interference